Bifogade filer
Interim Report Q2 2024
Kurs
+6,85%
Likviditet
3,78 MSEK
Prenumeration
Kalender
| Tid* | ||
| 2026-02-12 | 08:00 | Bokslutskommuniké 2025 |
| 2025-10-23 | 08:00 | Kvartalsrapport 2025-Q3 |
| 2025-07-17 | 08:00 | Kvartalsrapport 2025-Q2 |
| 2025-04-24 | 08:00 | Kvartalsrapport 2025-Q1 |
| 2025-02-13 | 08:00 | Bokslutskommuniké 2024 |
| 2024-10-24 | - | Kvartalsrapport 2024-Q3 |
| 2024-07-18 | - | Kvartalsrapport 2024-Q2 |
| 2024-05-10 | - | X-dag ordinarie utdelning STIL 0.00 SEK |
| 2024-05-08 | - | Årsstämma |
| 2024-04-25 | - | Kvartalsrapport 2024-Q1 |
| 2024-02-16 | - | Bokslutskommuniké 2023 |
| 2023-12-29 | - | Extra Bolagsstämma 2023 |
| 2023-10-26 | - | Kvartalsrapport 2023-Q3 |
| 2023-07-14 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-08 | - | X-dag ordinarie utdelning STIL 1.80 SEK |
| 2023-05-05 | - | Årsstämma |
| 2023-04-27 | - | Kvartalsrapport 2023-Q1 |
| 2023-02-17 | - | Bokslutskommuniké 2022 |
| 2022-10-27 | - | Kvartalsrapport 2022-Q3 |
| 2022-07-15 | - | Kvartalsrapport 2022-Q2 |
| 2022-05-06 | - | X-dag ordinarie utdelning STIL 1.00 SEK |
| 2022-05-05 | - | Årsstämma |
| 2022-05-01 | - | Kvartalsrapport 2022-Q1 |
| 2022-02-17 | - | Bokslutskommuniké 2021 |
| 2021-10-27 | - | Kvartalsrapport 2021-Q3 |
| 2021-07-16 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-05 | - | X-dag ordinarie utdelning STIL 1.70 SEK |
| 2021-05-04 | - | Årsstämma |
| 2021-04-28 | - | Kvartalsrapport 2021-Q1 |
| 2021-02-18 | - | Bokslutskommuniké 2020 |
| 2020-10-29 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-20 | - | Kvartalsrapport 2020-Q2 |
| 2020-05-28 | - | X-dag ordinarie utdelning STIL 0.00 SEK |
| 2020-05-27 | - | Årsstämma |
| 2020-04-29 | - | Kvartalsrapport 2020-Q1 |
| 2020-02-20 | - | Bokslutskommuniké 2019 |
| 2019-10-31 | - | Kvartalsrapport 2019-Q3 |
| 2019-08-22 | - | Kvartalsrapport 2019-Q2 |
| 2019-05-03 | - | X-dag ordinarie utdelning STIL 1.45 SEK |
| 2019-05-02 | - | Årsstämma |
| 2019-05-02 | - | Kvartalsrapport 2019-Q1 |
| 2019-02-25 | - | Bokslutskommuniké 2018 |
| 2018-11-22 | - | Kvartalsrapport 2018-Q3 |
| 2018-08-23 | - | Kvartalsrapport 2018-Q2 |
| 2018-05-17 | - | Kvartalsrapport 2018-Q1 |
| 2018-04-23 | - | X-dag ordinarie utdelning STIL 1.20 SEK |
| 2018-04-20 | - | Årsstämma |
| 2018-02-22 | - | Bokslutskommuniké 2017 |
| 2017-11-16 | - | Kvartalsrapport 2017-Q3 |
| 2017-08-24 | - | Kvartalsrapport 2017-Q2 |
| 2017-05-18 | - | Kvartalsrapport 2017-Q1 |
| 2017-04-27 | - | X-dag ordinarie utdelning STIL 1.00 SEK |
| 2017-04-26 | - | Årsstämma |
| 2017-02-16 | - | Bokslutskommuniké 2016 |
| 2016-11-17 | - | Kvartalsrapport 2016-Q3 |
| 2016-08-25 | - | Kvartalsrapport 2016-Q2 |
| 2016-05-19 | - | Kvartalsrapport 2016-Q1 |
| 2016-04-29 | - | X-dag ordinarie utdelning STIL 0.80 SEK |
| 2016-04-28 | - | Årsstämma |
| 2016-02-18 | - | Bokslutskommuniké 2015 |
| 2015-11-17 | - | Kvartalsrapport 2015-Q3 |
| 2015-08-25 | - | Kvartalsrapport 2015-Q2 |
| 2015-05-19 | - | Kvartalsrapport 2015-Q1 |
| 2015-04-16 | - | X-dag ordinarie utdelning STIL 0.00 SEK |
| 2015-04-15 | - | Årsstämma |
| 2015-02-18 | - | Bokslutskommuniké 2014 |
| 2014-11-19 | - | Kvartalsrapport 2014-Q3 |
| 2014-08-28 | - | Kvartalsrapport 2014-Q2 |
| 2014-07-30 | - | X-dag ordinarie utdelning STIL 1.00 SEK |
| 2014-05-14 | - | Kvartalsrapport 2014-Q1 |
| 2014-04-03 | - | Årsstämma |
| 2014-02-20 | - | Bokslutskommuniké 2013 |
| 2013-11-28 | - | Kvartalsrapport 2013-Q3 |
| 2013-08-29 | - | Kvartalsrapport 2013-Q2 |
| 2013-05-28 | - | Kvartalsrapport 2013-Q1 |
| 2013-04-26 | - | X-dag ordinarie utdelning STIL 0.00 SEK |
| 2013-04-25 | - | Årsstämma |
| 2013-02-20 | - | Bokslutskommuniké 2012 |
| 2012-11-20 | - | Kvartalsrapport 2012-Q3 |
| 2012-08-29 | - | Kvartalsrapport 2012-Q2 |
| 2012-05-16 | - | Kvartalsrapport 2012-Q1 |
| 2012-04-19 | - | X-dag ordinarie utdelning STIL 0.00 SEK |
| 2012-04-18 | - | Årsstämma |
| 2012-02-15 | - | Bokslutskommuniké 2011 |
| 2011-11-16 | - | Kvartalsrapport 2011-Q3 |
| 2011-08-24 | - | Kvartalsrapport 2011-Q2 |
| 2011-05-18 | - | Kvartalsrapport 2011-Q1 |
| 2011-04-14 | - | X-dag ordinarie utdelning STIL 0.00 SEK |
| 2011-04-13 | - | Årsstämma |
| 2011-02-16 | - | Bokslutskommuniké 2010 |
| 2010-11-24 | - | Kvartalsrapport 2010-Q3 |
| 2010-08-18 | - | Kvartalsrapport 2010-Q2 |
| 2010-04-16 | - | X-dag ordinarie utdelning STIL 0.00 SEK |
| 2010-04-15 | - | Kvartalsrapport 2010-Q1 |
| 2010-02-19 | - | Bokslutskommuniké 2009 |
| 2009-11-20 | - | Kvartalsrapport 2009-Q3 |
| 2009-08-27 | - | Kvartalsrapport 2009-Q2 |
| 2009-05-15 | - | X-dag ordinarie utdelning STIL 0.00 SEK |
| 2009-05-14 | - | Kvartalsrapport 2009-Q1 |
| 2009-04-15 | - | Årsstämma |
| 2008-06-24 | - | Split STIL 100:1 |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Stille AB (publ) today presents the report for the second quarter and first half of the year 2024.
Revenue amounted to MSEK 142.6 (75.1) driven by strong organic growth in surgical instruments and the acquisition of Fehling. Total growth amounted to 89.9 percent, of which 7.4 percent was organic growth.
“It is encouraging to see that organic growth remains robust, despite strong comparable figures.”, says Torbjörn Sköld and continues, “We are particularly pleased with the continued successful integration of Fehling and that our continual efforts
to improve our pricing, purchasing, production and quality are having a positive effect on our operations.”
The gross profit amounted to 49.3 percent (44.6) and operating profit before one-time costs amounted to MSEK 29.1 (11.9).
”2024 has continued on a high note – our products are delivering value to our customers, which is creating favorable demand, strong growth and a healthy cash flow.”, concludes Stille’s CEO.
| MSEK | APR-JUN 2024 | APR-JUN 2023 | JAN-JUN 2024 | JAN-JUN 2023 | JUL-JUN 2023/24 | JAN-DEC 2023 |
| Net sales | 142.6 | 75.1 | 282.3 | 147.5 | 429.7 | 294.9 |
| Gross profit, % | 49.3 | 44.6 | 48.9 | 43.5 | 50.2 | 44.8 |
| EBITDA before non-recurring items | 36.0 | 15.7 | 69.6 | 29.4 | 102.8 | 62.6 |
| EBITDA before non-recurring items, % | 25.2 | 20.9 | 24.7 | 20.0 | 23.9 | 21.2 |
| EBITDA | 32.6 | 15.7 | 49.6 | 26.1 | 82.8 | 59.3 |
| EBITDA, % | 22.9 | 20.9 | 17.6 | 17.7 | 20.0 | 20.1 |
| Operating profit before non-recurring items | 29.1 | 11.9 | 56.1 | 22.4 | 81.9 | 48.3 |
| Operating profit before non-recurring items, % | 20.4 | 15.9 | 19.9 | 15.2 | 21.0 | 16.4 |
| Operating profit | 25.7 | 11.9 | 36.0 | 19.1 | 61.9 | 45.0 |
| Operating profit, % | 18.0 | 15.9 | 12.8 | 12.9 | 15.1 | 15.2 |
Torshälla, July 18th, 2024.
Contact Details
Torbjörn Sköld
CEO & President
+46 (0)70 316 63 91 | torbjorn.skold@stille.se
This information is information that Stille is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2024-07-18 08:00 CEST.
About Us
Stille AB (publ) develops, manufactures and markets medical devices for surgeons across the world. Stille was founded in 1841 and is one of the world’s oldest medical device companies. Stille’s main business areas are surgical instruments and c-arm tables. Stille’s surgical instruments are mostly used during different kinds of open surgery. During minimal invasive procedures. the c-arm tables imagiQ2 and Medstone are key products. The company has a strong brand and products of a renowned high-quality. The share is listed on First North Growth Market under the acronym “STIL” with Eminova AB as Certified Adviser, Eminova Fondkommission AB, + 46 8 684 211 10, adviser@eminova.se. For more information, visit www.stille.se.
Attachments
Interim Report Q2 2024